Conference Description:

The First Industry Forum for Translational Experts, Neuroscience Drug Sponsors and Biomarker Technology Developers to Transform Earlier Assessment of AD, PD, ALS and MS

Development and integration of validated, inexpensive, non-invasive, and reliable fluid and imaging biomarkers are critical to advance neurodegenerative and neuro-immunological drug candidates through clinical trials.

Built to provide cutting-edge insights across emerging biomarker technologies and address the current translational bottleneck hindering your pipeline's success: the inaugural Fluid and Imaging Biomarkers in Neuroscience Summit is an unrivaled new opportunity to evaluate the latest biomarker research across AD, PD, MS and ALS, in one highly focused forum.

Unite with translational experts and biomarker specialists from the likes of Biogen, Eli Lilly, and Janssen to engage in forward-thinking discussions to meaningfully advance biomarker assessments of neurodegenerative and neuroinflammatory disease-modifying therapeutics.

URL:
Tickets: https://go.evvnt.com/1646471-2?pid=154
Prices:
Drug Developer Pricing | Conference + 2 Workshops: USD 3597.00,
Drug Developer Pricing | Conference + 1 Workshop: USD 3098.00,
Drug Developer Pricing | Conference Only: USD 2599.00,
Solution Providers | Conference + 2 Workshops: USD 5297.00,
Solution Providers | Conference + 1 Workshop: USD 4548.00,
Solution Providers | Conference Only: USD 3799.00

Speakers: Anna Katrin Szardenings | Senior Director Global Imaging Biomarkers | Janssen, Ariana Farrand | Associate Director, Translational and Discovery Research | The Michael J. Fox Foundation for Parkinson's Research, Barbara Bendlin | Professor, Medicine | University of Wisconsin-Madison, Carol Taylor-Burds | Director - Program | National Institute of Health Science, Christopher Whelan | Director | Janssen, Danielle Graham | Head of Fluid Biomarkers | Biogen, Enchi Liu | Vice President - Translational Sciences | Tranquis Therapeutics Inc., Fan Liao | Principal Research Scientist | AbbVie, Francesca Capotosti | Senior Group Leader | AC Immune, Henrik Zetterberg | Professor and Chief Physician | University of Gothenburg, Kira Holmstrom | Head of Biomarker Research | Herantis Pharma, Kristina Holmberg | Director, Clinical Biomarkers | Biogen, Li Chin Wong | Executive Director | Eli Lilly, Lisa Shafer | Chief Scientific Officer | Cerebral Therapeutics LLC, Olga Kahn | Biomarker Scientist | Alector Pharmaceuticals LLC, Paul Mcquade | Senior Director - Scientific | Takeda Pharmaceutical Co. Ltd., Raj Rajagovindan | VP Clinical Development Sciences | Vigil Neuroscience, Robert Drolet | Principal Scientist | Merck, SUDHIR SIVAKUMARAN | Executive Director | Critical Path Institute, Wesley Horton | Senior Manager - Scientific Project and Neuroscience | Foundation for the National Institutes of Health

Category: Conferences | Science, Health and Medicine | Pharmaceuticals

Date and Time: 22nd August 2023 at 9:30 am to 24th August 2023 at 5:00 pm